University of Wisconsin Department of Urology

Joshua Lang, MD, MS discusses how emerging biomarkers may help personalize treatment decisions while highlighting barriers to precision oncology in prostate cancer.

The phase 1 study will assess the safety and feasibility of SPECT/CT imaging with [111In]In-ART-101.

Margaret A. Knoedler, MD, discusses her experience using the Reverse Deflection CVAC System.

The phase 1 study is set to begin later this year.

Margaret A. Knoedler, MD, discusses the advantages of using the MONARCH platform for mini-PCNL.

"The decision for which laser to use in your institution should be left up to the urologist and the hospital system," says Margaret A. Knoedler, MD.

“One of the things we do is communicate with our teams and help them with some guidance about how to make decisions about which patients can potentially be treated with alternative approaches,” says Hamid Emamekhoo, MD.

Hamid Emamekhoo, MD, explains his approach to discussing the ongoing cancer drug shortage with his patients with genitourinary cancers.

The shortage has been affecting the treatment of patients with genitourinary cancers, including bladder cancer.